News

Telmisartan, amlodipine, and chlorthalidone in a low-dose fixed triple combination –⁠ better control of target blood pressure values?

15. 6. 2022 Source: Sartans in the Treatment of Hypertension

The secondary analysis of the TRIUMPH study, recently published in JAMA Cardiology, is likely the first published assessment of time spent in the target blood pressure (BP) range during antihypertensive treatment. This parameter was assessed in patients with moderate hypertension using a low-dose triple combination of antihypertensives (telmisartan 20 mg, amlodipine 2.5 mg, and chlorthalidone 12.5 mg) compared to usual care.

Joystick-operated robot intervening in stroke treatment remotely −⁠ fiction or promise of the future?

A team of experts from the Massachusetts Institute of Technology (MIT) has developed a telerobotic system that could allow doctors to treat stroke or brain aneurysm remotely in the future. Scientists…

15. 6. 2022 Source: medScope.pro

Current Indications for Negative Pressure Therapy in Wound Healing in Orthopedic and Traumatological Patients

Negative pressure wound therapy was introduced in North America in 1997. Since then, the method has gained great popularity and is used in the treatment of many acute and chronic wounds. Like any…

14. 6. 2022 Source: Wound Healing

Which Dietary Recommendations Actually Work for Irritable Bowel Syndrome?

Food is both a trigger for symptoms and a treatment tool for individuals with irritable bowel syndrome (IBS). A 2021 review summarizes the results of the latest research on the effectiveness of…

13. 6. 2022 Source: Irritable Bowel Syndrome

Efficacy and Safety of Enoxaparin in Hospitalized Patients with Severe Renal Insufficiency

A study evaluating the effect of thromboprophylaxis with enoxaparin at a dose of 20 mg/day in adult patients with renal failure compared the incidence of venous thromboembolism (VTE) with published…

13. 6. 2022 Source: Thromboprophylaxis

Anticoagulants and Antiplatelets in the Treatment of Acute Coronary Syndromes

Anticoagulants and antiplatelets are a key part of the therapeutic strategies used in the treatment of acute coronary syndromes (ACS). They reduce the risk of acute and late complications, morbidity,…

13. 6. 2022 Source: Thromboprophylaxis

Bilastine and its role in the treatment of allergic rhinoconjunctivitis and urticaria in children

The prevalence of allergic rhinitis (AR) in the pediatric population is estimated worldwide at 10-20%. The efficacy and safety of bilastine (a second-generation antihistamine) in adult patients and…

10. 6. 2022 Source: Allergic Reactions

Prevention and Treatment of Thromboembolism in the Elderly

Despite advances in the prevention and treatment of venous thromboembolism, morbidity and mortality associated with this condition remain high in certain risk groups. An international expert group…

9. 6. 2022 Source: Thromboprophylaxis

Three tests to confirm the diagnosis of acquired hemophilia –⁠ infographic

Acquired hemophilia (AHA) typically manifests with spontaneous bleeding in patients with no prior personal history of significant bleeding.^1–4 The cause of the bleeding is a significant decrease in…

8. 6. 2022 Source: Acquired Hemophilia

Innovative Form of Levothyroxine Ensures Accurate Dosing for Patients

In the treatment of hypothyroidism, precise dosing of replacement therapy is critical. An innovative formulation of levothyroxine has been developed to meet the updated, stricter standards of regulatory...

8. 6. 2022 Source: Thyroid Disorders

1 … 74 75 76 77 78 … 171

Back Filter by speciality

Remove filters